Literature DB >> 8229699

Multiple-dose pharmacokinetics of moxisylyte after oral administration to healthy volunteers.

P Costa1, F Bressolle, E Jarroux, B Sarrazin, J Mosser, H Navratil, M Galtier.   

Abstract

The pharmacokinetics of moxisylyte in plasma and urine was investigated after oral administration. Twelve subjects were treated orally, twice daily with 240 mg of the drug for 6 days; on day 7, the subjects received a last dose of 240 mg of moxisylyte. Moxisylyte was assayed in plasma and urine by a specific HPLC method with fluorimetric detection. Moxisylyte was absorbed rapidly and changed to its metabolites immediately after drug administration; unchanged moxisylyte was not found in plasma. Two metabolites were found in plasma and urine: conjugated desacetylmoxisylyte (DAM) and the conjugate of desmethylated DAM (MDAM). The pharmacokinetic parameters determined after the first oral administration were not modified on multiple dosing. The apparent elimination half-lives of conjugated DAM and MDAM were 2.3 and 3.5 h, respectively. Elimination of these two metabolites in urine averaged 50 and 10%, respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229699     DOI: 10.1002/jps.2600820920

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Pharmacokinetics of moxisylyte in healthy volunteers after intracavernous injection of increasing doses.

Authors:  F Bressolle; P Costa; R Rouzier-Panis; C Marquer
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

2.  A Kinetic Model for Simultaneous Fit of Clozapine and Norclozapine Concentrations in Chronic Schizophrenic Patients during Long-Term Treatment.

Authors:  C Guitton; J M Kinowski; R Gomeni; F Bressolle
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.